Revolution Medicines Reports Preclinical Tumor Regressions Induced by First-in-Class KRAS-G12D(ON) Inhibitors

Element Science Names Zubin J. Eapen, MD as Chief Medical Officer

Voyager Therapeutics Appoints Nancy Vitale To Its Board Of Directors

Rhythm Pharmaceuticals Appoints Yann Mazabraud as Executive Vice President, Head of International

Voyager Therapeutics Appoints Michelle Quinn Smith As Chief Human Resources Officer